Azathioprine-induced pure red-cell aplasia

Nephrology Dialysis Transplantation

Volumn 11, Issue 7, 1996, Pages 1371-1373

  Pruijt, J F M ^a   Haanen, J B A G ^a   Hollander, A A M J ^a   Den Ottolander, G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Azathioprine; Kidney transplantation; Pure red cell aplasia

Indexed keywords

AZATHIOPRINE;

ARTICLE; CLINICAL ARTICLE; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; LONG TERM CARE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIABETIC NEPHROPATHY; MIDDLE AGED; REVIEW;

AZATHIOPRINE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; RED-CELL APLASIA, PURE;

EID: 0029666495     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.7.1371     Document Type: Article

References (20)

1. McGrath BP, Ibels LS, Raik E, Hargrave M, Mahony JF, Stewart JH. Erythroid toxicity of azathioprine. Q J Med 1975; 44: 57-63
2. Declerck YA, Ettinger RB, Orlega JA, Permisi AJ. Macrocytosis and pure RBC anemia caused by azathioprine. Am J Dis Child 1980; 134: 377-379
3. Kissel JT, Levy RJ, Mendell JR, Griggs RC. Azathioprine toxicity in neuromuscular disease. Neurology 1986; 36: 35-39
4. Wickramasinghe SN, Dodsworth H, Rault RMJ, Hulme B. Observation on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation. Transplantation 1974; 18: 443-446
5. Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34: 1081-1085
6. Singh G., Fries JF, Spitz P, Williams CA. Toxic effects of azathioprine in rheumatoid arthritis. Arthritis Rheum 1989; 32: 837-843
7. Old CW, Flannery EP, Grogan IM. Azathioprine-induced pure red-cell aplasia. JAMA 1978; 240: 552-556
8. Flury W, Montandon A. Isolierte erythroide Aplasie unter immunsuppressiver Therapie mit Azathioprin nach Niertransplantation. Schweiz Med Wochenschr 1980; 110: 1614-1616
9. Hogge DE, Wilson DR, Shumak KH, Cattran DC. Reversible azathioprine-induced erythrocyte aplasia in a renal transplant recipient. Can Med Assoc J 1982; 126: 512-514
10. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 641-649
11. Creemers GJ, van Boven WPL, Löwenberg B, van der Heul C. Azathioprine-associated pure red cell aplasia. J Int Med 1993; 233: 85-87
12. Agarwal SK, Mittal D, Tiwari SC et al. Azathioprine-induced pure red-cell aplasia in a renal transplant recipient. Nephron 1993; 63: 471
13. Krantz SB. Pure red-cell aplasia: biology and treatment. In: Feig SA, Freedman MH, eds. Clinical Disorders and Experimental Models of Erythropoietic Failure. CRC Press, Boca Raton, Florida, 1993; 86-127
14. Dessypris EN, Redline S, Harris JW, Krantz SB, Diphenylhydantoin-induced pure red cell aplasia. Blood 1985; 65: 789-794
15. Yunis AA, Arimura GK, Lutcher CL et al. Biochemical lesion in Dilantin-induced erythroid aplasia. Blood 1967; 30: 587-600
16. Hoffman R, McPhedram P, Benz EJ, Duffy TP. Isoniazid-induced pure red cell aplasia. Am J Med Sci 1983; 286(1): 2-9
17. Giannone L, Kugler JW, Krantz SB. Pure red-cell aplasia associated with administration of sustained-release procainamide. Arch Intern Med 1987; 147: 1179-1180
18. Anstey A, Lennard L, Mayou SC, Kirby JD. Pancytopenia related to azathioprine, an enzyme deficiency caused by a common genetic polymorphism: a review. J Roy Soc Med 1992; 85: 752-756
19. Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989; 46: 149-154
20. Kerstens PJSM. Stolk JN, Hilbrands LB, van de Putte LBA, De Abreu RA, Boerbooms AMT. 5-Nucleotidase and azathioprine-related toxicity. Lancet 1993; 342: 1245-1246